Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.50
Bid: 33.00
Ask: 36.00
Change: -1.00 (-2.82%)
Spread: 3.00 (9.091%)
Open: 35.50
High: 35.50
Low: 34.50
Prev. Close: 35.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Sports Direct Expects Earnings To Beat Forecasts

Thu, 28th May 2015 10:35

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 WINNERS
-------
Sports Direct International, up 4.3%. The sporting goods retailer said it will provide an update on its outlook for the financial year to April 26 at its annual conference on Thursday, saying underlying earnings before interest, taxation, depreciation and amortisation will be in line with market expectations, while both underlying pretax profit and earnings per share are set to be ahead.

Kingfisher, up 3.4%. The DIY retailer reported a drop in total revenue in the first quarter of its financial year as it was hit by adverse currency movements, but said it is making good progress with its turnaround plans. The retailer reported total sales of GBP2.59 billion for the 13 weeks to May 2, which is a 4.6% decline on the same period the year before, but would have been an increase of 2.7% had exchange rates remained constant. The group's performance was boosted by a strong performance in the UK and Ireland where total sales grew 2.9%.

International Consolidated Airlines Group, up 1.5%. The company said its EUR2.55 per share offer for Irish flag carrier Aer Lingus Group is its final offer and will not be raised. Aer Lingus shares are flat at EUR2.44. Aer Lingus shareholder Ryanair is down 1.3% at EUR11.60.

Direct Line Insurance Group, up 1.3%. JP Morgan has upgraded the motor insurer to Overweight from Neutral.
-------
FTSE 100 LOSERS
-------
Intertek Group, down 1.6%. Deutsche Bank has downgraded the testing, certification and inspection services provider to Hold from Buy.

Marks & Spencer Group, down 1.3%, and Whitbread, down 0.8%. The companies have gone ex-dividend, meaning new buyers no longer qualify for the latest dividend payouts.

Glencore, down 1.2%. Private equity group First Reserve Corp is to sell the remaining part of its stake in mining and commodities company Glencore, Reuters reported.
-------
FTSE 250 WINNERS
-------
PayPoint, up 6.2%. The payments services company reported higher pretax profit in its last financial year, driven by growth in its retail networks, and hiked its dividend on the back of the results. It said it made a GBP49.6 million pretax profit in the year ended March 31, compared with GBP46.0 million in the prior year. Revenue increased by 3.0% to GBP218.5 million due to growth across its retail networks, with margins improving.

Infinis Energy, up 3.7%. The British renewable energy company said it swung to profit from a substantial loss in the last financial year leading the company to significantly raise its dividend, as expected, as the expansion of its wind farms continues to progress on schedule.

Zoopla Property Group, up 2.6%. Jefferies has raised its price target for the online property portal to 400.00 pence from 269.00p, reiterating its Buy rating. Zoopla currently trades at 246.20p.

Premier Oil, up 2.3%. The companies involved in the Isobel deep exploration well offshore the Falkland Islands said they have made an oil discovery that has similar properties to the discovery made at the Sea Lion project. Premier Oil is the operator of the well with 36% stake. Shares in partner Falkland Oil and Gas are down 3.4%, while those of third partner Rockhopper Exploration are up 7.7%.
-------
FTSE 250 LOSERS
-------
SOCO International, down 4.1%, AMEC Foster Wheeler, down 3.7%, Cable & Wireless Communications, down 2.3%, Spectris, down 1.9%, Premier Farnell, down 1.9%, Inchcape, down 1.3% and Marston's, down 1.3%. The companies have gone ex-dividend.

Tate & Lyle, down 3.3%. The sugar and sweeteners company reported a huge drop in profit in its recently-ended financial year after suffering from issues with its supply chain, a weak performance from its bulk ingredients business, and tough market conditions for its SPLENDA Sucralose product.

ICAP, down 2.3%. Numis has cut the inter-dealer broker to Sell from Hold.
-------
AIM ALL-SHARE WINNERS
-------
Connemara Mining Co, up 23%. The company said it has received encouraging initial results from the Inishowen gold licences in Donegal in Ireland. Connemara said the initial results indicate quartz vein boulders up to 45 centimetres in diameter containing robust gold grades. The gold grades obtained in the initial results range up to 15.35 grams per tonne, the company said.

Stellar Diamonds, up 12%. The company said it has almost reached USD1.0 million in sales during 2015 after completing another auction of diamonds from the Baoule project in Guinea. The company said it raised USD505,000 before costs in the latest auction which was held online and brought the total sales for the year to USD922,000, which has mainly come from diamonds extracted from Baoule.

Camco Clean Energy, up 12%. The clean energy and energy storage company said it has struck a deal to sell its US carbon credit portfolio for a total of USD2.24 million.
-------
AIM ALL-SHARE LOSERS
-------
Marimedia, off 38%. The online advertising technology company said it anticipates its 2015 results will be materially below market expectations owing to a decision by the company to exit the display advertising sector and focus solely on mobile.

Northbridge Industrial Services, down 25%. The company said it sees "no reliable signs of any upturn" in the oil and gas sector in 2015 and said it expects to make a loss in the first half as the company slashes jobs and expenditure whilst closing and selling some of its operations to mitigate the difficulties in the sector.

Sareum Holdings, down 22%. The company said it has raised GBP1.4 million in a discounted share placing. Sareum said it had raised the funding via the issue of 577.4 million shares at 0.25 pence per share. The net proceeds are to be used to back its drug development programmes and for working capital. Sareum currently trades at 0.2795p.

Belgravium Technologies, down 15%. The mobile computing services company said it has secured a recent order for mobile systems but said delays to the contract will hit its first-half results.

Gable Holdings, down 10%. The non-life insurer said it swung to a loss in 2014 as it provided additional reserves to reduce a gap between the reserves it carries and the actuarial best estimate. Gable's pretax loss amounted to GBP5.4 million in 2014, a significant reversal from the GBP7.2 million pretax profit reported for the prior year.
-------
By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
26 Feb 2014 12:01

Sareum Shares Drop As Pretax Loss Widens

LONDON (Alliance News) - Shares in Sareum Holdings PLC slid 12% Wednesday as its pretax loss widened in the half-year ended December 31, 2013. The specialist cancer drug discovery and development business posted a pretax loss of GBP375,000, widened from GBP305,000 in the previous year, due

Read more
22 Jan 2014 10:27

Sareum Receives Patent As It Progresses Cancer Treatment To Trials

LONDON (Alliance News) - Sareum Holdings PLC said Wednesday that it had received a patent from the US Patent and Trademark Office for one of the inventions associated to its CHK1 cancer treatment programme. The patent covers compounds developed by Sareum and Cancer Research UK-funded scient

Read more
2 Dec 2013 14:17

Sareum Holdings does cancer drug deal in China

Cancer drug developer Sareum Holdings has signed a deal with a Chinese medical university to progress its Aurora+FLT3 cancer programme. Sareum has granted the Hebei Medical University Biomedical Engineering Center exclusive rights to carry out pre-clinical and clinical studies within Greater China

Read more
1 Nov 2013 12:52

UK WINNERS & LOSERS: Vodafone Up But Meggitt Slides After Warning

Read more
1 Nov 2013 12:34

Sareum raises funds for further drug development

Sareum Holdings, a cancer drug discovery and development business, has placed 278.5m shares at 0.6p each, it announced Friday. The group raised a conditional £1.67m before expenses from the placing, which it said was oversubscribed. The proceeds of the placing will provide funds to facilitate the

Read more
1 Nov 2013 10:48

CORRECT: Sareum Slides After Placing To Raise Funds For Development Programmes

Read more
1 Nov 2013 10:17

Sareum Slides After Placing To Raise Funds For Development Programmes

Read more
24 Sep 2013 07:35

Sareum Holdings In Co-Development Deal For Cancer Treatment

Read more
22 Apr 2013 08:06

Sareum Holdings and SRI International develop drug for inflammatory diseases

Cancer drug discovery business Sareum Holdings has entered into a co-development agreement with research institute SRI International. The two have joined forces to advance Sareum's Tyrosine Kinase 2 (TYK2) small molecule drug discovery programme for readiness in human clinical trials. Research wi

Read more
18 Feb 2013 08:21

Sareum shares fall following interims and research update

Shares in AIM-listed Sareum Holdings, the specialist cancer drug discovery business, fell sharply on Monday morning after the company unveiled its half yearly results alongside a research update. Cash at bank as of December 31st fell 28% to £380,000 and the company reported a loss on ordinary activ

Read more
7 Feb 2013 08:27

Sareum share price climbs on US patent grant announcement

The share price of AIM-listed specialist cancer drug discovery business Sareum Holdings jumped sharply on Thursday after the company announced that a patent was due to be awarded in the US for one of its key drug discovery inventions. The patent, which is expected on February 19th, relates to compo

Read more
12 Dec 2012 10:40

Sareum share price plummets ahead of AGM

The likelihood that specialist cancer drug discovery business Sareum will conclude a deal to commercialise a research programme this year has fallen, according to an announcement made ahead of its annual general meeting (AGM) on Wednesday morning. During the AGM, Dr. Paul Harper, the company's Chai

Read more
10 Sep 2012 14:37

Small caps round-up: Sareum, Lonrho, FFastFill

Sareum, a specialist cancer drug discovery business, has entered into a four million pound Standby Equity Distribution Agreement (SEDA) with YA Global Master, an investment fund to provide a flexible source of future funding to the company to support its on-going drug research activities. It will a

Read more
7 Aug 2012 11:25

Small caps round-up: YouGov, Sareum and InterQuest...

Environmental Recycling Technologies, which owns the rights to the Powder Impression Moulding (PIM) process which is capable of converting mixed waste plastics into commercially viable products, has confirmed that its US parent application, entitled 'Process for Forming Plastic, Apparatuses for Form

Read more
19 Jul 2012 12:07

Small caps round-up: Byotrol, sareum, KDD ...

Byotrol, an anti-microbial hygiene company, has continued to make progress and has maintained the momentum seen in the second half of last year into the current financial year. The balance sheet continues to remain strong and is well positioned to its objective of positive cash generation at the ear

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.